查詢結果分析
相關文獻
- Octreotide Effect on Hypersecretion of Growth Hormone in a Patient with Fibrous Dysplasia: A Case Report
- 肢端肥大症的診斷及治療
- 肢端肥大症的內科治療
- The Suppression of Blood Growth Hormone Level by Somatostatin Infusion in Patients with Active Acromegaly
- 肢端肥大症之藥品治療
- 肢端肥大症案例報告
- 肢端肥大症的診斷、治療及治療後的長期追蹤
- Somatostatin Analogs的進展與在肢端肥大症的臨床使用經驗談
- 肢端肥大症
- 肢端肥大症的診斷與治療
頁籤選單縮合
題 名 | Octreotide Effect on Hypersecretion of Growth Hormone in a Patient with Fibrous Dysplasia: A Case Report=善得定對骨頭纖維化發育異常合併生長激素過度分泌的療效:一病例報告 |
---|---|
作 者 | 陳涵栩; 胡啟民; 石光中; 郭清輝; 何橈通; | 書刊名 | 中華醫學雜誌 |
卷 期 | 62:8 1999.08[民88.08] |
頁 次 | 頁554-559 |
分類號 | 415.939 |
關鍵詞 | 肢端肥大症; 骨頭纖維化發育異常; 生長激素; 善得定; Acromegaly; Fibrous dysplasia; Growth hormone; Octreotide; |
語 文 | 英文(English) |
英文摘要 | We report the case of a 17-year-old adolescent boy with polyostotic fibrous dysplasia and hypersecretion of growth hormone (GH). The fasting serum GH, insulin-like growth factor-I (IGF-I), alkaline phosphatase activity and osteocalcin levels were all elevated. The GH secretion was stimulated by thyrotropin-releasing hormone and was not suppressed by an oral glucose test. Magnetic resonance imaging of the sella turcica showed no abnormal findings. The patient was treated with octreotide, 100 micrograms subcutaneous injection three times a day for two weeks to observe the effects of octreotide on growth hormone secretion. GH and IGF-I secretions were suppressed by octreotide therapy, while alkaline phosphatase activity and osteocalcin secretion were partially suppressed. We suggest that the high bone turnover states in this patient may be attributed to both hypersecretion of growth hormone and the polyostotic fibrous dysplasia itself. |
本系統中英文摘要資訊取自各篇刊載內容。